Agreement to License VAL401 to Ambrose Healthcare | 05-Dec-2023 | 07:00 | RNS |
Evaluation Agreement with StingRay Bio | 10-Nov-2023 | 07:00 | RNS |
Statement re Share Price Movement | 06-Oct-2023 | 10:45 | RNS |
Operational Review | 28-Sep-2023 | 07:00 | RNS |
Half-year Report | 24-Aug-2023 | 07:00 | RNS |
Collaborative Services Agreement | 14-Aug-2023 | 07:00 | RNS |
Result of AGM | 28-Jun-2023 | 14:15 | RNS |
Conclusion of Hokkaido Evaluation Agreement | 16-Jun-2023 | 07:00 | RNS |
Asset Purchase – Imagen Therapeutics | 14-Jun-2023 | 07:00 | RNS |
Update on proposed sub-license of VAL201 | 08-Jun-2023 | 07:00 | RNS |
Expanded agreement with University of Barcelona | 07-Jun-2023 | 07:00 | RNS |
Final Results and Notice of AGM | 05-Jun-2023 | 07:00 | RNS |
Notice of Results and Investor Webinar | 26-May-2023 | 07:00 | RNS |
Collaborative Services Agreement | 26-Apr-2023 | 07:00 | RNS |
Quarterly Operational Update | 31-Mar-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 3.35p |
Change Today | 0.050p |
% Change | 1.52 % |
52 Week High | 14.13p |
52 Week Low | 3.30p |
Volume | 164,059 |
Shares Issued | 132.35m |
Market Cap | £4.43m |
RiskGrade | 435 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:25 | 22,500 @ 3.35p |
16:13 | 70,000 @ 3.33p |
16:00 | 45 @ 3.40p |
15:53 | 12,500 @ 3.40p |
15:18 | 56,047 @ 3.39p |
You are here: research